Straightline Group LLC Makes New $205,000 Investment in Oscar Health, Inc. (NYSE:OSCR)

Straightline Group LLC purchased a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 15,272 shares of the company’s stock, valued at approximately $205,000.

Other large investors have also recently modified their holdings of the company. FMR LLC grew its holdings in Oscar Health by 29.5% during the 3rd quarter. FMR LLC now owns 109,002 shares of the company’s stock worth $2,312,000 after acquiring an additional 24,801 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Oscar Health by 29.2% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 353,491 shares of the company’s stock valued at $7,498,000 after purchasing an additional 79,801 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of Oscar Health by 27.1% during the third quarter. Janus Henderson Group PLC now owns 72,236 shares of the company’s stock valued at $1,532,000 after purchasing an additional 15,400 shares in the last quarter. Stifel Financial Corp increased its holdings in Oscar Health by 14.3% during the third quarter. Stifel Financial Corp now owns 151,589 shares of the company’s stock valued at $3,215,000 after buying an additional 18,952 shares during the period. Finally, State Street Corp raised its stake in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after buying an additional 291,335 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

OSCR has been the topic of a number of analyst reports. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Jefferies Financial Group initiated coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $20.21.

Oscar Health Stock Down 3.8 %

Shares of OSCR stock opened at $12.51 on Tuesday. The stock’s fifty day moving average price is $14.53 and its 200 day moving average price is $15.68. Oscar Health, Inc. has a 1-year low of $11.89 and a 1-year high of $23.79. The company has a market cap of $3.13 billion, a price-to-earnings ratio of -624.94 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.